Related Experiment Video
Updated: May 15, 2026
09:19
Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
Published on: December 8, 2017
Glia and epilepsy: excitability and inflammation
Orrin Devinsky1, Annamaria Vezzani, Souhel Najjar
1Epilepsy Center, Department of Neurology, NYU School of Medicine, New York, NY 10016, USA. od4@nyu.edu
Trends in Neurosciences
|January 10, 2013
Summary
Epilepsy involves brain neuron hyperexcitability. This review explores how non-neuronal glia, like astrocytes and microglia, contribute to epilepsy and inflammation, offering new therapeutic insights.
Area of Science:
- Neuroscience
- Cell Biology
- Pathophysiology
Background:
- Epilepsy is a neurological disorder marked by recurrent seizures, primarily attributed to neuronal dysfunction.
- Current antiepileptic drugs target neuronal mechanisms but are ineffective in about one-third of patients.
- This highlights the need for a deeper understanding of epilepsy pathophysiology.
Purpose of the Study:
- To critically evaluate the role of glial cells, specifically astrocytes and microglia, in epilepsy.
- To investigate how glia contribute to neuronal hyperexcitability and inflammation in epilepsy.
- To explore potential therapeutic targets beyond neuronal mechanisms.
Main Methods:
- Literature review of recent studies on glial cells in epilepsy.
- Analysis of research linking glial activation to hyperexcitability and seizure generation.
- Examination of the role of neuroinflammation in epileptic conditions.
Main Results:
- Glial cells, including astrocytes and microglia, play a significant role in epilepsy.
- Glia contribute to neuronal hyperexcitability and hypersynchrony, key features of epilepsy.
- Glial-mediated inflammation is increasingly recognized as a critical factor in epilepsy.
Conclusions:
- Non-neuronal cells, particularly glia, are crucial players in epilepsy pathophysiology.
- Targeting glial cells and associated inflammation may offer novel therapeutic strategies for refractory epilepsy.
- Further research into glia-neuron interactions is essential for developing more effective epilepsy treatments.
Related Concept Videos
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:04Glial Cells
Overview
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...